Survivors for Solutions Opposes Medicare Part B Reimbursement Cuts
Medicare Part B covers the treatments many patients depend on for serious and complex conditions. Yet buried within the Inflation Reduction Act (IRA) are provisions that will slash Medicare Part B reimbursement rates, threatening patient access to these critical treatments. Survivors for Solutions believes patients deserve policies that strengthen access to care rather than undermine it.
Medicare Part B supports access to complex, provider-administered treatments such as cancer therapies, biologics, and infusions, along with outpatient services and certain medical equipment. These treatments must be delivered in clinical settings and are essential for patients with serious and chronic conditions.
The IRA’s Medicare “negotiation” program will lower Part B reimbursement by replacing the current formula with a government-set “Maximum Fair Price” (MFP) formula, reducing provider payments and squeezing independent practices that purchase and administer these drugs.
Lower reimbursement threatens patient access and community-based care. As margins tighten, clinics may stop offering certain therapies, consolidate into hospital systems, or close altogether, particularly in rural and underserved areas. The result can be fewer treatment options, longer travel distances, delayed care, and higher overall system costs.
Survivors for Solutions supports fixing the IRA’s Part B negotiation and reimbursement provisions to protect patient access, stabilize community-based providers, and ensure patients can continue receiving critical treatments.
Survivors for Solutions commissioned a national poll of voters and found overwhelming bipartisan support for reforms that protect patients and providers. Polling resources: